Insomnia in the elderly: cause, approach, and treatment

The American Journal of Medicine
Nabil S Kamel, Julie K Gammack

Abstract

Insomnia is a prevalent problem in late life. Sleep problems in the elderly are often mistakenly considered a normal part of aging. Insomnia, the most common sleep disorder, is a subjective report of insufficient or nonrestorative sleep despite adequate opportunity to sleep. Despite the fact that more than 50% of elderly people have insomnia, it is typically undertreated, and nonpharmacologic interventions are underused by health care practitioners. This article will review the causes of insomnia in the elderly, the approach to patient evaluation, and the nonpharmacologic and pharmacologic treatment of insomnia.

References

Nov 1, 1996·Neurologic Clinics·W H Obermeyer, R M Benca
Jan 30, 1997·The New England Journal of Medicine·D J Kupfer, C F Reynolds
Feb 25, 1998·Journal of the American Geriatrics Society·S MaggiG Enzi
Mar 12, 1999·Annual Review of Medicine·A N Vgontzas, A Kales
Mar 23, 1999·JAMA : the Journal of the American Medical Association·C M MorinD Brink
Aug 25, 1999·Psychiatry and Clinical Neurosciences·R KobayashiT Koyama
Jul 18, 2000·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·S I BarbarS F Quan
Oct 19, 2000·Journal of the American Geriatrics Society·G S BrassingtonD L Bliwise
Sep 18, 2001·Journal of the American Geriatrics Society·M CriccoD J Foley
Jan 5, 2002·The American Journal of Psychiatry·Michael T SmithDaniel J Buysse
Nov 9, 2002·BMJ : British Medical Journal·Paul Montgomery
Feb 21, 2004·Journal of the American College of Cardiology·Hans K Meier-EwertJanet M Mullington
Mar 12, 2004·Primary Care Companion to the Journal of Clinical Psychiatry·Sonia Ancoli-IsraelMasamoto Fujimori
Mar 17, 2004·Health Information and Libraries Journal·Lotta Haglund
Feb 18, 2005·Sleep Medicine·Sonia Ancoli-IsraelWalter S Jones
Apr 27, 2005·Archives of Internal Medicine·Daniel J GottliebF Javier Nieto

Citations

Jul 7, 2011·International Journal of Clinical Pharmacy·Kristina Johnell, Johan Fastbom
May 12, 2007·Pituitary·Mark Sherlock, Andrew A Toogood
Apr 23, 2008·International Urology and Nephrology·Nazmiye EryavuzM Tugrul Sezer
Apr 29, 2010·Current Psychiatry Reports·Joshua C Magee, Cheryl N Carmin
Sep 16, 2010·Current Treatment Options in Neurology·Kyoung Bin ImMark Eric Dyken
Aug 4, 2010·International Psychogeriatrics·Luca CravelloGianfranco Spalletta
Feb 21, 2009·Human Reproduction Update·Giuseppe FanciulliGiuseppe Delitala
Sep 7, 2007·Ear and Hearing·Sylvie Hébert, Julie Carrier
Nov 14, 2006·Journal of Neurology, Neurosurgery, and Psychiatry·M D GjerstadJ P Larsen
Nov 21, 2007·CNS Drugs·Seithikurippu R Pandi-PerumalDaniel P Cardinali
Apr 1, 2010·The British Journal of General Practice : the Journal of the Royal College of General Practitioners·Andrea LasserreThomas Hanslik
Jul 17, 2007·Primary Care Companion to the Journal of Clinical Psychiatry·Lawrence T ParkTheodore A Stern
Sep 4, 2010·Annals of Indian Academy of Neurology·Sahoo Saddichha
Apr 27, 2010·Journal of Endocrinological Investigation·F LanfrancoM Maccario
Aug 13, 2014·Enfermería clínica·Judit Vico-RomeroMateu Serra-Prat
May 9, 2013·Journal of Behavioral Medicine·Galit ArmonAmiram Vinokur
Jul 8, 2011·The Consultant Pharmacist : the Journal of the American Society of Consultant Pharmacists·Pamela ForalMark Malesker
Oct 4, 2014·Zeitschrift für Gerontologie und Geriatrie·J SchlitzerH Frohnhofen
Feb 4, 2016·Geriatrics & Gerontology International·Mi Jeong Park, Kon Hee Kim
Apr 28, 2012·Physical Medicine and Rehabilitation Clinics of North America·Laurentiu Iulius DinescuKarishma Patel
Oct 25, 2011·Neuropharmacology·Christopher J WinrowJohn J Renger
Apr 2, 2011·Progress in Neuro-psychopharmacology & Biological Psychiatry·Venkatramanujan SrinivasanGregory M Brown
Sep 1, 2011·The EPMA Journal·Tatjana Crönlein, Jürgen Zulley
Mar 27, 2010·Archives of Gerontology and Geriatrics·Gianluca IsaiaMauro Zanocchi
Aug 4, 2009·Rheumatic Diseases Clinics of North America·I Jon Russell, Alice A Larson
Jun 28, 2008·Journal of Psychosomatic Research·Galit ArmonSamuel Melamed
Feb 26, 2008·Pharmacology, Biochemistry, and Behavior·Stephanie C Licata, James K Rowlett
Nov 13, 2007·The American Journal of Geriatric Pharmacotherapy·Louis J MiniJeff Zhang
Nov 14, 2007·Journal of the American Medical Directors Association·John E Morley
Feb 24, 2007·Archives of Gerontology and Geriatrics·L TafaroM Cacciafesta
Apr 4, 2009·International Journal of Geriatric Psychiatry·Seyed Kazem MalakoutiTaher Zandi
Jan 22, 2009·International Journal of Geriatric Psychiatry·Oye GurejeBenjamin O Olley
Jan 6, 2009·Journal of the American Academy of Nurse Practitioners·Preetha Krishnan, Pamela Hawranik
Jun 21, 2012·Psychogeriatrics : the Official Journal of the Japanese Psychogeriatric Society·Xiao Yan LiaoKiyoko Makimoto
Sep 17, 2010·International Journal of Geriatric Psychiatry·Tareef Al-AamaMonidipa Dasgupta
Apr 13, 2013·International Journal of Nursing Practice·Jin-Hee ParkSun Hyoung Bae
Sep 5, 2013·Journal of the American Geriatrics Society·Carlos A Vaz FragosoRichard A Marottoli
Mar 18, 2015·International Wound Journal·Ulrika KällmanMargareta Lindgren
Sep 28, 2010·The American Journal of Medicine·Jolanta Roszkowska, Stephen A Geraci
Nov 24, 2007·Clinics in Geriatric Medicine·Miguel A Paniagua, Elizabeth W Paniagua
Apr 6, 2013·Expert Opinion on Pharmacotherapy·Ariana Smith, Alan Wein
Jul 21, 2012·Drug Metabolism and Pharmacokinetics·Chia-Hsien ChangLi-Jen Lin
Aug 6, 2014·Evidence-based Complementary and Alternative Medicine : ECAM·Olaf KelberKarin Kraft
Mar 12, 2010·Journal of Korean Academy of Nursing·Sohyune R Sok, Jin Yi Choi

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Hereditary Sensory Autonomic Neuropathy

Hereditary Sensory Autonomic Neuropathies are a group of inherited neurodegenerative disorders characterized clinically by loss of sensation and autonomic dysfunction. Here is the latest research on these neuropathies.

Glut1 Deficiency

Glut1 deficiency, an autosomal dominant, genetic metabolic disorder associated with a deficiency of GLUT1, the protein that transports glucose across the blood brain barrier, is characterized by mental and motor developmental delays and infantile seizures. Follow the latest research on Glut1 deficiency with this feed.

Regulation of Vocal-Motor Plasticity

Dopaminergic projections to the basal ganglia and nucleus accumbens shape the learning and plasticity of motivated behaviors across species including the regulation of vocal-motor plasticity and performance in songbirds. Discover the latest research on the regulation of vocal-motor plasticity here.

Neural Activity: Imaging

Imaging of neural activity in vivo has developed rapidly recently with the advancement of fluorescence microscopy, including new applications using miniaturized microscopes (miniscopes). This feed follows the progress in this growing field.

Nodding Syndrome

Nodding Syndrome is a neurological and epileptiform disorder characterized by psychomotor, mental, and growth retardation. Discover the latest research on Nodding Syndrome here.

LRRK2 & Microtubules

Mutations in the LRRK2 gene are risk-factors for developing Parkinson’s disease (PD). LRRK2 mutations in PD have been shown to enhance its association with microtubules. Here is the latest research.

Related Papers

Depression and Anxiety
Christopher L DrakeThomas Roth
Journal of the American Geriatrics Society
M CriccoD J Foley
Psychiatric Services : a Journal of the American Psychiatric Association
R M Benca
© 2021 Meta ULC. All rights reserved